M&T Bank Corp Bio Techne Corp Transaction History

M&T Bank Corp

$28.6 Billion
Q2 2025

A detailed history of M&T Bank Corp transactions in Bio Techne Corp stock. As of the latest transaction made, M&T Bank Corp holds 12,499 shares of TECH stock, worth $793,186. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,499

Previous 11,723 6.62%

Holding current value

$793,186

Previous $687,000 6.4%

% of portfolio

0.0%

Previous 0.0%

34 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$46.66 - $58.38 $36,208 - $45,302	776 Added 6.62%	12,499 $643,000
Q1 2025 Apr 30, 2025	SELL	$58.47 - $78.75 $130,680 - $176,006	-2,235 Reduced 16.01%	11,723 $687,000
Q4 2024 Feb 06, 2025	SELL	$66.37 - $78.17 $37,034 - $43,618	-558 Reduced 3.84%	13,958 $1.01 Million
Q3 2024 Nov 15, 2024	SELL	$70.96 - $82.35 $5,605 - $6,505	-79 Reduced 0.54%	14,516 $1.16 Million
Q2 2024 Jul 31, 2024	BUY	$62.12 - $84.15 $43,111 - $58,400	694 Added 4.99%	14,595 $1.05 Million
Q1 2024 May 07, 2024	BUY	$65.98 - $77.09 $44,668 - $52,189	677 Added 5.12%	13,901 $978,000
Q4 2023 Feb 06, 2024	BUY	$52.83 - $78.22 $12,415 - $18,381	235 Added 1.81%	13,224 $1.02 Million
Q3 2023 Nov 02, 2023	SELL	$67.52 - $89.42 $112,015 - $148,347	-1,659 Reduced 11.33%	12,989 $884,000
Q2 2023 Aug 09, 2023	BUY	$73.76 - $85.98 $95,297 - $111,086	1,292 Added 9.67%	14,648 $1.2 Million
Q1 2023 May 11, 2023	BUY	$71.62 - $86.62 $26,499 - $32,049	370 Added 2.85%	13,356 $990,000
Q4 2022 Feb 13, 2023	BUY	$80.67 - $352.29 $88,010 - $384,348	1,091 Added 9.17%	12,986 $1.08 Million
Q4 2022 Feb 13, 2023	BUY	$80.67 - $352.29 $827,996 - $3.62 Million	10,264 Added 629.31%	11,895 $985,000
Q3 2022 Nov 14, 2022	SELL	$282.54 - $391.85 $12,996 - $18,025	-46 Reduced 2.74%	1,631 $448,000
Q2 2022 Aug 05, 2022	BUY	$322.67 - $449.65 $52,917 - $73,742	164 Added 10.84%	1,677 $539,000
Q1 2022 May 09, 2022	SELL	$353.85 - $487.79 $434,527 - $599,006	-1,228 Reduced 44.8%	1,513 $656,000
Q4 2021 Feb 07, 2022	BUY	$456.15 - $525.06 $4,561 - $5,250	10 Added 0.37%	2,741 $1.42 Million
Q3 2021 Oct 28, 2021	SELL	$444.87 - $538.88 $52,494 - $63,587	-118 Reduced 4.14%	2,731 $1.32 Million
Q2 2021 Aug 13, 2021	SELL	$387.35 - $450.26 $145,256 - $168,847	-375 Reduced 11.63%	2,849 $1.28 Million
Q1 2021 May 06, 2021	SELL	$314.62 - $411.0 $32,091 - $41,922	-102 Reduced 3.07%	3,224 $1.23 Million
Q4 2020 Feb 12, 2021	SELL	$246.9 - $321.87 $23,208 - $30,255	-94 Reduced 2.75%	3,326 $1.06 Million
Q3 2020 Nov 06, 2020	BUY	$232.22 - $282.96 $57,126 - $69,608	246 Added 7.75%	3,420 $848,000
Q2 2020 Jul 29, 2020	BUY	$185.43 - $279.56 $73,059 - $110,146	394 Added 14.17%	3,174 $839,000
Q1 2020 May 14, 2020	BUY	$161.17 - $221.51 $64,629 - $88,825	401 Added 16.86%	2,780 $528,000
Q4 2019 Feb 07, 2020	SELL	$189.68 - $222.09 $17,829 - $20,876	-94 Reduced 3.8%	2,379 $522,000
Q3 2019 Nov 12, 2019	BUY	$183.56 - $216.72 $183 - $216	1 Added 0.04%	2,473 $484,000
Q2 2019 Aug 12, 2019	SELL	$188.72 - $215.43 $12,832 - $14,649	-68 Reduced 2.68%	2,472 $516,000
Q1 2019 May 15, 2019	SELL	$136.09 - $200.44 $24,360 - $35,878	-179 Reduced 6.58%	2,540 $505,000
Q4 2018 Feb 01, 2019	SELL	$132.75 - $203.8 $79,517 - $122,076	-599 Reduced 18.05%	2,719 $393,000
Q3 2018 Nov 09, 2018	SELL	$147.44 - $204.11 $33,026 - $45,720	-224 Reduced 6.32%	3,318 $677,000
Q2 2018 Aug 10, 2018	SELL	$144.9 - $165.58 $4,491 - $5,132	-31 Reduced 0.87%	3,542 $523,000
Q1 2018 May 04, 2018	SELL	$131.46 - $151.04 $9,202 - $10,572	-70 Reduced 1.92%	3,573 $540,000
Q4 2017 Feb 06, 2018	SELL	$121.17 - $134.75 $18,539 - $20,616	-153 Reduced 4.03%	3,643 $473,000
Q3 2017 Nov 13, 2017	BUY	$113.59 - $123.78 $67,245 - $73,277	592 Added 18.48%	3,796 $458,000
Q2 2017 Aug 11, 2017	BUY	N/A	3,204	3,204 $376,000

Others Institutions Holding TECH

# of Institutions

612

Shares Held

161M

Call Options Held

225K

Put Options Held

80.8K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.49B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.

Account